06/05/2026
What does it take to go from pharmacy school to developing cutting-edge cancer and autoimmune therapies at one of the world's leading biopharma companies? For Noah Kaitz (PharmD '23), it took just two years.
It started with the School of Pharmacy's Research path in the PharmD program, which required him to design and execute an original research project, present his findings, and publish a manuscript as first author.
Today, he's a clinical scientist at Bristol Myers Squibb, working on Phase 1 trials in oncology and autoimmune cell therapy, helping to assess safety, guide dose-finding, and advance promising therapies.
"The foundational research experiences I gained through the Research path prepared me to think critically about how scientific experiments are designed, as well as how to interpret and analyze scientific data," says Noah. "A core part of my work now involves interpreting data to help answer complex questions."
Learn more about his work and how specialized courses helped to get him where he is today: https://bit.ly/4bYs2G6